130 related articles for article (PubMed ID: 36439951)
21. CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner.
Liu X; Liu Y; Liu Z; Lin C; Meng F; Xu L; Zhang X; Zhang C; Zhang P; Gong S; Wu N; Ren Z; Song J; Zhang Y
Mol Cancer; 2021 Sep; 20(1):114. PubMed ID: 34496888
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer.
Noda M; Okayama H; Kofunato Y; Chida S; Saito K; Tada T; Ashizawa M; Nakajima T; Aoto K; Kikuchi T; Sakamoto W; Endo H; Fujita S; Saito M; Momma T; Ohki S; Kono K
PLoS One; 2018; 13(7):e0200315. PubMed ID: 29975776
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of p53 protein expression and TP53 variation status in colorectal cancer.
Kim KM; Ahn AR; Park HS; Jang KY; Moon WS; Kang MJ; Ha GW; Lee MR; Chung MJ
BMC Cancer; 2022 Aug; 22(1):940. PubMed ID: 36045334
[TBL] [Abstract][Full Text] [Related]
24. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer.
Chen TH; Huang CC; Yeh KT; Chang SH; Chang SW; Sung WW; Cheng YW; Lee H
World J Gastroenterol; 2012 Aug; 18(30):4051-8. PubMed ID: 22912557
[TBL] [Abstract][Full Text] [Related]
25. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
Gong H; Cao Y; Han G; Zhang Y; You Q; Wang Y; Pan Y
Int J Oncol; 2017 May; 50(5):1785-1791. PubMed ID: 28339062
[TBL] [Abstract][Full Text] [Related]
26. Different mutation profiles associated to P53 accumulation in colorectal cancer.
López I; P Oliveira L; Tucci P; Alvarez-Valín F; A Coudry R; Marín M
Gene; 2012 May; 499(1):81-7. PubMed ID: 22373952
[TBL] [Abstract][Full Text] [Related]
27. Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors.
Li H; Zhang J; Tong JHM; Chan AWH; Yu J; Kang W; To KF
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795192
[TBL] [Abstract][Full Text] [Related]
28. Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models.
Jalali-Najafabadi F; Stadler M; Dand N; Jadon D; Soomro M; Ho P; Marzo-Ortega H; Helliwell P; Korendowych E; Simpson MA; Packham J; Smith CH; Barker JN; McHugh N; Warren RB; Barton A; Bowes J; ;
Sci Rep; 2021 Dec; 11(1):23335. PubMed ID: 34857774
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of combining E-cadherin, p53, Bcl-2 and Bcl-xL expression and survival in Tunisian colorectal adenocarcinoma patients.
Jamai D; Kallel I; Mekrezi S; Walha M; Gharsallah M; Khabir A; Selmi B
Cell Mol Biol (Noisy-le-grand); 2022 Apr; 68(4):93-107. PubMed ID: 35988276
[TBL] [Abstract][Full Text] [Related]
30. MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.
Zhou S; Lu J; Li Y; Chen C; Cai Y; Tan G; Peng Z; Zhang Z; Dong Z; Kang T; Tang F
J Exp Clin Cancer Res; 2018 Nov; 37(1):284. PubMed ID: 30477538
[TBL] [Abstract][Full Text] [Related]
31. P53-induced MRVI1 mediates carcinogenesis of colorectal cancer.
Ma L; Wang H; Sun Y; Yang D; Pu L; Zhang X
Scand J Gastroenterol; 2020 Jul; 55(7):824-833. PubMed ID: 32589066
[No Abstract] [Full Text] [Related]
32. Prognostic value of p53 for colorectal cancer after surgical resection of pulmonary metastases.
Li C; Xu Q; Chen L; Luo C; Chen Y; Ying J
World J Surg Oncol; 2016 Dec; 14(1):308. PubMed ID: 28003030
[TBL] [Abstract][Full Text] [Related]
33. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
[TBL] [Abstract][Full Text] [Related]
34. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
[TBL] [Abstract][Full Text] [Related]
35. Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients.
Paradiso A; Simone G; Petroni S; Leone B; Vallejo C; Lacava J; Romero A; Machiavelli M; De Lena M; Allegra CJ; Johnston PG
Br J Cancer; 2000 Feb; 82(3):560-7. PubMed ID: 10682666
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
[TBL] [Abstract][Full Text] [Related]
37. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
38. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
39. [Peripheral blood p53 single nucleotide polymorphism analysis for early diagnosis of colorectal carcinoma].
Liu Q; Lai ZS; Wnag W; Zhang Y; Zhou M
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1939-40. PubMed ID: 18159026
[TBL] [Abstract][Full Text] [Related]
40. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
